If you’ve been experiencing mild-to-moderate symptoms of COVID-19*** within the last 2–3 days, and you are at high risk of severe disease, we need your help. You may qualify to participate in a clinical study that is testing the effectiveness of an investigational medication designed to prevent COVID-19 disease from becoming more severe. This is especially important for those who are at higher risk of severe illness because of age or underlying chronic health conditions, such as:
- diabetes
- obesity (BMI over 30)
- kidney disease
- congestive heart failure
- chronic obstructive pulmonary disease
- moderate-to-severe asthma
- 55 years of age or older
***COVID-19 symptoms include fever, chills, cough, sore throat, a general feeling of weakness or discomfort, headache, joint or muscle pain, change in smell or taste, vomiting, diarrhea, or shortness of breath during physical activity.
